Condition
Post-COVID / Long-COVID clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Post-COVID / Long-COVID clinical trials that are recruiting, at sites in 2 countries (most in Germany (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Sipavibart antibody treatment for Long COVID
This Phase II randomized, placebo-controlled trial will test whether the monoclonal antibody Sipavibart can reduce Long COVID symptoms in adults who had confirmed COVID-19 and still have symptoms after three months.
-
Cold water hydrotherapy to support rehabilitation in Post-COVID Syndrome
This tests whether adding cold water hydrotherapy to standard rehabilitation helps people with Post-COVID Syndrome improve their quality of life.
Related topics
Quick answers
How many Post-COVID / Long-COVID clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Germany (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.